Research into respiratory infections is an urgent priority, they argue. Colds can be a very serious problem for the elderly, babies, and patients with lung disease. History suggests a major flu pandemic is overdue and drug resistant tuberculosis and other 'superbugs' are on the rise.
The new Centre for Respiratory Infection at Imperial College London aims to tackle these issues. It is funded by a £3.4 million award from the Wellcome Trust and will bring together more than 200 scientists to work on a range of problems - how common cold viruses cause disease and affect long-term health, how to make better vaccines to prevent lung infections, and how to diagnose TB more accurately. The centre will also be ready to spring into action if there is a new outbreak of pandemic flu such as a mutated form of bird flu, or SARS.
Professor Peter Openshaw, the Director of the new centre from the National Heart and Lung Institute at Imperial College London, said: "Respiratory disease has never been as well funded as it deserves to be, considering the impact it has on health. Respiratory infections are at the root of many of the diseases that we treat every day. This new initiative is a great opportunity to get something done. We have a lot of very talented groups working on different aspects of lung infections, and bringing them together with solid shared support will help them work on common goals, to the great benefit of patients".
Examples of problems which the centre will tackle include:
* How to quickly bring a flu pandemic under control
Researchers from the new centre are establishing a clinical team that will bring doctors and researchers together to bring a future flu pandemic under control quickly and effectively.
If an outbreak of pandemic flu strikes, doctors will only be able to get the best treatments to patients if they can first analyse the flu strain and find out which therapies are going to work. However, planning and setting up the necessary trials to obtain this information would usually take months.
The new centre will put plans in place in advance, so that researchers can get to work before the epidemic spreads too widely and so that doctors working on the ground are fully prepared.
The researchers will be working closely with colleagues at Imperial College Healthcare NHS Trust and the MRC Centre for Outbreak Analysis and Modelling at Imperial College London, and with other scientists and government agencies across the world.
Professor Openshaw explained: "We can only move fast to bring an epidemic under control if we have staff ready and plans already in place. To plan at the stage when patients start coming in through casualty will be impossible."
* Why the common cold in babies can cause long term health problems
The respiratory syncytial virus (RSV), which causes colds in adults, is the main single cause of hospitalisation in babies under a year of age. It causes most cases of viral bronchiolitis, an infection of the small airways of the lung which leads to breathing problems and which results about 1 in every 40 babies affected being admitted to hospital. Around 40 percent of infants who experience bronchiolitis as a result of RSV infection are affected by recurring wheeze and asthma in childhood.
The researchers will investigate why some babies get severe disease, while the majority recover with ease. Imperial College researchers have already made many important discoveries about RSV, including a study in 2004 which revealed that RSV can 'hit and hide', surviving in the body for many months or years. They are now investigating whether recurrent wheezing in children could be caused by the virus hiding in the lung.
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences